InvestorsHub Logo
Followers 45
Posts 7008
Boards Moderated 0
Alias Born 02/24/2004

Re: None

Saturday, 09/30/2017 8:26:40 AM

Saturday, September 30, 2017 8:26:40 AM

Post# of 8023
VCEL will be with some large company speakers this Wednesday at 9.15am,
IMPLICATIONS OF COMMERCIALIZATION: WHAT DOES APPROVAL MEAN?

http://www.meetingonthemesa.com/agenda/

Speakers:
Bob Azelby, EVP, Chief Commercial Officer, Juno Therapeutics
Nick Colangelo, President and CEO, Vericel Corporation
Pascal Touchon, D.V.M., SVP and Global Head, Cell and Gene, Novartis Oncology
Jeffrey Walsh, Chief Financial and Strategy Officer, bluebird bio


http://www1.salary.com/Robert-Azelby-Salary-Bonus-Stock-Options-for-JUNO-THERAPEUTICS-INC.html

https://www.novartisoncology.com/sites/www.novartisoncology.com/files/Novartis_Bio_Pascal_Touchon.pdf

http://www1.salary.com/Jeffrey-T-Walsh-Salary-Bonus-Stock-Options-for-BLUEBIRD-BIO-INC.html

VCEL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News